“Another shipment hold.”
The midnight text message joins a week’s worth of similar alerts on your phone. By morning, 3 deliveries sit in limbo, their products unable to move forward. What began as occasional paperwork issues has evolved into persistent headaches, with compliance exceptions now consuming valuable team hours and creating bottlenecks throughout your distribution network.
Look at any pharma supply chain in 2025, and you’ll see the same story. Our latest benchmark report, “Unlocking value in supply chain track & trace solutions,” found 41% of pharma companies wasting countless hours on manual rework, while 31% highlighted data exchange errors as a top concern.
And that’s precisely what our UniTrace® track & trace solution aims to solve.
Whether you’re dealing with EPCIS data errors or shipping delays, the day in the life of a pharma supply chain professional in 2025 isn’t easy. That’s why, regardless of where you are in the world, exception management and handling determines if products move or money burns.
The clock is ticking loudly for DSCSA compliance deadlines. These staggered timelines give you breathing room to fine-tune exception handling—but they’re also creating chaos between trading partners at different stages.
Your operation faces a daily gauntlet of common exception scenarios.
Meanwhile, walk through any distributor warehouse and spot the growing “quarantine zones” built for exception handling. Manual rechecks drive labor costs skyward while FDA warning risks loom.
The Windsor Framework (from 2023) officially came into effect in January 2025 and now haunts your EU operations. Northern Ireland’s UKNI system disconnection from the EU Hub means UK packs flowing through Europe trigger constant alerts: “Market not found”- #A22. “Batch not found”- #A2. “Unknown product code”- #A1. And unlike technical glitches, these political exceptions demand manual resolution.
False alerts still drain resources daily. March 2024 EMVO data shows false alert rates between 0.16% and 1.17% across seven countries—better than the early 6% rates but nowhere near the 0.05% target. Add in the 4.67% of cases triggering incorrect quarantines during offline authentication, and your error management team never catches a break.
Greece and Italy are approaching EU FMD implementation (with Italy getting a two-year extension until 2027), but the promised standardized protocols for handling suspected falsifications remain fragmented across member states. Your team juggles different alert handling rules for each country while the European Commission’s standardization efforts move at bureaucratic speed.
Ever found yourself explaining to executives why $2 million in product is stuck in quarantine over a barcode error? That’s where our tried-and-true UniTrace track and trace solution comes into play to simplify serialization and traceability.
Honestly? Sometimes it feels like pharma serialization is paying a fortune for the privilege of creating your own problems. But UniTrace flips that equation with real results: Fewer alerts, faster resolutions and products that move instead of sitting quarantined. There’s a reason why Systech is trusted by 85% of the top 20 global pharmaceutical companies.
Contact Systech today and join the companies that have stopped dreading compliance.